• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

YTHDF2/m A/NF-κB 轴通过调节肿瘤内 Tregs 来控制抗肿瘤免疫。

YTHDF2/m A/NF-κB axis controls anti-tumor immunity by regulating intratumoral Tregs.

机构信息

Department of Chemistry, The University of Chicago, Chicago, IL, USA.

Department of Biochemistry and Molecular Biology, The University of Chicago, Chicago, IL, USA.

出版信息

EMBO J. 2023 Aug 1;42(15):e113126. doi: 10.15252/embj.2022113126. Epub 2023 Jun 22.

DOI:10.15252/embj.2022113126
PMID:37345898
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10390869/
Abstract

N -methyladenosine (m A) in messenger RNA (mRNA) regulates immune cells in homeostasis and in response to infection and inflammation. The function of the m A reader YTHDF2 in the tumor microenvironment (TME) in these contexts has not been explored. We discovered that the loss of YTHDF2 in regulatory T (Treg) cells reduces tumor growth in mice. Deletion of Ythdf2 in Tregs does not affect peripheral immune homeostasis but leads to increased apoptosis and impaired suppressive function of Treg cells in the TME. Elevated tumor necrosis factor (TNF) signaling in the TME promotes YTHDF2 expression, which in turn regulates NF-κB signaling by accelerating the degradation of m A-modified transcripts that encode NF-κB-negative regulators. This TME-specific regulation of Treg by YTHDF2 points to YTHDF2 as a potential target for anti-cancer immunotherapy, where intratumoral Treg cells can be targeted to enhance anti-tumor immune response while avoiding Treg cells in the periphery to minimize undesired inflammations.

摘要

N6-甲基腺苷(m6A)在信使 RNA(mRNA)中调节免疫细胞的稳态和对感染及炎症的反应。m6A 读码蛋白 YTHDF2 在这些情况下的肿瘤微环境(TME)中的功能尚未被探索。我们发现,YTHDF2 在调节性 T(Treg)细胞中的缺失会减少小鼠体内的肿瘤生长。Treg 细胞中 Ythdf2 的缺失不影响外周免疫稳态,但会导致 TME 中 Treg 细胞的凋亡增加和抑制功能受损。TME 中肿瘤坏死因子(TNF)信号的升高会促进 YTHDF2 的表达,进而通过加速降解编码 NF-κB 负调控因子的 m6A 修饰转录本来调节 NF-κB 信号。YTHDF2 对 Treg 的这种 TME 特异性调节表明 YTHDF2 是癌症免疫治疗的一个潜在靶点,其中可以靶向肿瘤内 Treg 细胞以增强抗肿瘤免疫反应,同时避免外周 Treg 细胞以最小化不必要的炎症。

相似文献

1
YTHDF2/m A/NF-κB axis controls anti-tumor immunity by regulating intratumoral Tregs.YTHDF2/m A/NF-κB 轴通过调节肿瘤内 Tregs 来控制抗肿瘤免疫。
EMBO J. 2023 Aug 1;42(15):e113126. doi: 10.15252/embj.2022113126. Epub 2023 Jun 22.
2
YTHDF2 inhibition potentiates radiotherapy antitumor efficacy.YTHDF2 抑制增强放疗抗肿瘤疗效。
Cancer Cell. 2023 Jul 10;41(7):1294-1308.e8. doi: 10.1016/j.ccell.2023.04.019. Epub 2023 May 25.
3
m6A Reader YTHDF2 Regulates LPS-Induced Inflammatory Response.m6A 阅读器 YTHDF2 调节 LPS 诱导的炎症反应。
Int J Mol Sci. 2019 Mar 15;20(6):1323. doi: 10.3390/ijms20061323.
4
YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated mA modification to activate NF-κB and promote the malignant progression of glioma.YTHDF2 通过识别 METTL3 介导的 mA 修饰来促进 UBXN1 mRNA 的降解,从而激活 NF-κB 并促进神经胶质瘤的恶性进展。
J Hematol Oncol. 2021 Jul 10;14(1):109. doi: 10.1186/s13045-021-01124-z.
5
The m6A Reader YTHDF2 Promotes Bladder Cancer Progression by Suppressing RIG-I-Mediated Immune Response.m6A 阅读器 YTHDF2 通过抑制 RIG-I 介导的免疫反应促进膀胱癌进展。
Cancer Res. 2023 Jun 2;83(11):1834-1850. doi: 10.1158/0008-5472.CAN-22-2485.
6
YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8 T cells.YTHDF2 通过 CD8 T 细胞协调肿瘤相关巨噬细胞重编程并控制抗肿瘤免疫。
Nat Immunol. 2023 Feb;24(2):255-266. doi: 10.1038/s41590-022-01398-6. Epub 2023 Jan 19.
7
Modified Biejia Jianwan decoction restrains PD-L1-mediated immune evasion through the HIF-1α/STAT3/NF-κB signaling pathway.加味鳖甲煎丸通过HIF-1α/STAT3/NF-κB信号通路抑制PD-L1介导的免疫逃逸。
J Ethnopharmacol. 2024 Mar 25;322:117577. doi: 10.1016/j.jep.2023.117577. Epub 2023 Dec 15.
8
YTHDF2 Regulates Macrophage Polarization through NF-B and MAPK Signaling Pathway Inhibition or p53 Degradation.YTHDF2 通过抑制 NF-B 和 MAPK 信号通路或降解 p53 来调节巨噬细胞极化。
Dis Markers. 2022 Oct 12;2022:3153362. doi: 10.1155/2022/3153362. eCollection 2022.
9
YTHDF2 Is a Therapeutic Target for HCC by Suppressing Immune Evasion and Angiogenesis Through ETV5/PD-L1/VEGFA Axis.YTHDF2 通过抑制 ETV5/PD-L1/VEGFA 轴抑制免疫逃逸和血管生成,是 HCC 的治疗靶点。
Adv Sci (Weinh). 2024 Apr;11(13):e2307242. doi: 10.1002/advs.202307242. Epub 2024 Jan 21.
10
YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8 T cell recruitment.癌周肝细胞中的 YTHDF2 通过 CX3CL1 介导的 CD8+T 细胞募集来介导化疗诱导的抗肿瘤免疫反应。
Mol Cancer. 2024 Sep 6;23(1):186. doi: 10.1186/s12943-024-02097-6.

引用本文的文献

1
mA-driven transcriptomic rewiring in tumor immune surveillance.毫安驱动的肿瘤免疫监视中的转录组重排
J Immunother Cancer. 2025 Sep 3;13(9):e012744. doi: 10.1136/jitc-2025-012744.
2
Immunosuppressive mechanisms and therapeutic targeting of regulatory T cells in ovarian cancer.卵巢癌中调节性T细胞的免疫抑制机制及治疗靶点
Front Immunol. 2025 Jul 9;16:1631226. doi: 10.3389/fimmu.2025.1631226. eCollection 2025.
3
Targeting YTHDF2 with pH-responsive siRNA nanoparticles suppresses MYC m6A modification and restores antitumor immunity in hepatocellular carcinoma.用pH响应性小干扰RNA纳米颗粒靶向YTHDF2可抑制MYC的N6-甲基腺苷修饰并恢复肝细胞癌的抗肿瘤免疫。
J Nanobiotechnology. 2025 Jul 1;23(1):469. doi: 10.1186/s12951-025-03538-0.
4
Epitranscriptomics Regulation of CD70, CD80, and TIGIT in Cancer Immunity.癌症免疫中CD70、CD80和TIGIT的表观转录组学调控
Int J Mol Sci. 2025 Jun 16;26(12):5772. doi: 10.3390/ijms26125772.
5
YTHDFs as radiotherapy checkpoints in tumor immunity.YTHDFs作为肿瘤免疫中的放射治疗检查点。
J Exp Med. 2025 Aug 4;222(8). doi: 10.1084/jem.20250272. Epub 2025 Jun 5.
6
Insulin‑like growth factor in cancer: New perspectives (Review).癌症中的胰岛素样生长因子:新视角(综述)
Mol Med Rep. 2025 Aug;32(2). doi: 10.3892/mmr.2025.13574. Epub 2025 May 26.
7
The role of YTHDF2 in anti-tumor immunity.YTHDF2在抗肿瘤免疫中的作用。
Cell Investig. 2025 Mar;1(1). doi: 10.1016/j.clnves.2025.100008. Epub 2025 Feb 26.
8
Biological functions of 5-methylcytosine RNA-binding proteins and their potential mechanisms in human cancers.5-甲基胞嘧啶RNA结合蛋白的生物学功能及其在人类癌症中的潜在机制
Front Oncol. 2025 Feb 7;15:1534948. doi: 10.3389/fonc.2025.1534948. eCollection 2025.
9
RNA modifications in cancer.癌症中的RNA修饰
MedComm (2020). 2025 Jan 10;6(1):e70042. doi: 10.1002/mco2.70042. eCollection 2025 Jan.
10
ADAMDEC1 promotes the malignant progression of cholangiocarcinoma by regulating NF-κB signaling pathway.ADAMDEC1通过调节NF-κB信号通路促进胆管癌的恶性进展。
Sci Rep. 2025 Jan 4;15(1):817. doi: 10.1038/s41598-025-85241-6.

本文引用的文献

1
The function of Wtap in N-adenosine methylation of mRNAs controls T cell receptor signaling and survival of T cells.Wtap 在 mRNA 的 N-腺苷甲基化中的功能控制着 T 细胞受体信号和 T 细胞的存活。
Nat Immunol. 2022 Aug;23(8):1208-1221. doi: 10.1038/s41590-022-01268-1. Epub 2022 Jul 25.
2
YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated mA modification to activate NF-κB and promote the malignant progression of glioma.YTHDF2 通过识别 METTL3 介导的 mA 修饰来促进 UBXN1 mRNA 的降解,从而激活 NF-κB 并促进神经胶质瘤的恶性进展。
J Hematol Oncol. 2021 Jul 10;14(1):109. doi: 10.1186/s13045-021-01124-z.
3
Inhibition of YTHDF2 triggers proteotoxic cell death in MYC-driven breast cancer.YTHDF2 的抑制会触发 MYC 驱动型乳腺癌中的蛋白毒性细胞死亡。
Mol Cell. 2021 Aug 5;81(15):3048-3064.e9. doi: 10.1016/j.molcel.2021.06.014. Epub 2021 Jul 2.
4
The RNA m6A reader YTHDF2 controls NK cell antitumor and antiviral immunity.YTHDF2,一种 RNA m6A 阅读器,调控 NK 细胞抗肿瘤和抗病毒免疫。
J Exp Med. 2021 Aug 2;218(8). doi: 10.1084/jem.20210279. Epub 2021 Jun 23.
5
RNA mA reader YTHDF2 facilitates lung adenocarcinoma cell proliferation and metastasis by targeting the AXIN1/Wnt/β-catenin signaling.RNA mA 读码器 YTHDF2 通过靶向 AXIN1/Wnt/β-catenin 信号通路促进肺腺癌细胞的增殖和转移。
Cell Death Dis. 2021 May 13;12(5):479. doi: 10.1038/s41419-021-03763-z.
6
Histone lactylation drives oncogenesis by facilitating mA reader protein YTHDF2 expression in ocular melanoma.组蛋白乳酰化通过促进眼黑色素瘤中 mA 读码蛋白 YTHDF2 的表达来驱动肿瘤发生。
Genome Biol. 2021 Mar 16;22(1):85. doi: 10.1186/s13059-021-02308-z.
7
Chromatin and transcriptional regulation by reversible RNA methylation.RNA 可逆甲基化调控染色质和转录。
Curr Opin Cell Biol. 2021 Jun;70:109-115. doi: 10.1016/j.ceb.2020.11.005. Epub 2021 Mar 9.
8
m A RNA methylation: from mechanisms to therapeutic potential.mRNA 甲基化:从机制到治疗潜力。
EMBO J. 2021 Feb 1;40(3):e105977. doi: 10.15252/embj.2020105977. Epub 2021 Jan 20.
9
The RNA m6A Reader YTHDF2 Maintains Oncogene Expression and Is a Targetable Dependency in Glioblastoma Stem Cells.RNA m6A 阅读器 YTHDF2 维持致癌基因表达,是神经胶质瘤干细胞的一个可靶向依赖性。
Cancer Discov. 2021 Feb;11(2):480-499. doi: 10.1158/2159-8290.CD-20-0331. Epub 2020 Oct 6.
10
Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects.肿瘤微环境中的调节性 T 细胞:新机制、潜在治疗策略和未来前景。
Mol Cancer. 2020 Jul 17;19(1):116. doi: 10.1186/s12943-020-01234-1.